Close Menu

E. coli and Listeria monocytogenes aren't the first things you think about when you think about curing disease. But to some researchers at this year's ASM conference, these bugs are exactly what the doctor ordered. The Therapeutic Use of Genetically Engineered Bacteria symposium highlighted new ideas from biotech and academia that call for the use of pathogenic bacteria to fight many diseases, including cancer. Dirk Brockstedt from Aduro BioTech in California presented his company's attempt at turning Listeria into an effective cancer vaccine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.